Form 4: Cabaletta Bio's General Counsel Acquires Stock Options
SEC Form 4 Filing
Michael Gerard, General Counsel of Cabaletta Bio, Inc., reports the acquisition of stock options.
Summary
- Michael Gerard, the General Counsel of Cabaletta Bio, Inc., filed a Form 4 on March 4, 2025, reporting a transaction.
- On March 3, 2025, Gerard acquired stock options for 115,000 shares of Cabaletta Bio's common stock at an exercise price of $1.67 per share.
- These options vest over time, with 25% vesting on March 3, 2026, and the remainder vesting in equal quarterly installments over the following three years, contingent upon continued service.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock option grants, which is neutral in sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be an indicator of management's confidence in the company's future prospects.
Stakeholder Impact
- The granting of stock options aligns management's interests with those of shareholders, potentially incentivizing performance and value creation.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the stock option transaction. |
| 03/03/2026 | Date when 25% of the stock options vest. |
| 03/02/2035 | Expiration date of the stock options. |
| 03/04/2025 | Date the Form 4 was signed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.